Our
Vision :
"A
Star Performer for Schering-Plough Worldwide"
"To earn trust, every day"
Incorporated
in Singapore in 1994
Started production in 1997
Our manufacturing facilities are operated to the highest standards and are approved by US FDA (Food & Drug Administration) and TGA (Australia Therapeutic Goods Administration) and European Authorities.
Schering-Plough is a worldwide pharmaceutical company committed to discovering, developing and marketing new therapies and treatment programs that can improve people’s health and extend lives. The company is a recognized leader in biotechnology, genomic and gene therapy. Core product groups are allergy and respiratory, anti-infective and anticancer, cardiovascular and dermatological.
In addition to our 3 existing manufacturing plants in Singapore, we are building 3 additional plants and an R&D facility; bringing our total investments to US$730 million. This makes SP one of the .
Our plants in Singapore manufacture a range of active pharmaceutical ingredients as well as final product forms such as inhalers, sterile biological Production and tablets.